Further processing options
The insulin-sensitizing agent troglitazone improves metabolic and reproductive abnormalities in the polycystic ovary syndrome.
Saved in:
Journal Title: | The Journal of Clinical Endocrinology & Metabolism |
---|---|
Authors and Corporations: | , , , , |
In: | The Journal of Clinical Endocrinology & Metabolism, 81, 1996, 9, p. 3299-3306 |
Type of Resource: | E-Article |
Language: | English |
published: |
The Endocrine Society
|
Subjects: |